ENTREP1

Chr 9

endosomal transmembrane epsin interactor 1

Also known as: C9orf61, ENTREP, FAM189A2, X123

This protein activates the E3 ubiquitin ligase ITCH to ubiquitinate the CXCR4 receptor, triggering its endocytosis and desensitization to negatively regulate CXCL12/CXCR4 signaling. Mutations cause autosomal recessive neurodevelopmental disorders with intellectual disability, seizures, and movement abnormalities. The gene shows minimal constraint against loss-of-function variants.

GeneReviewsOMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.11
Clinical SummaryENTREP1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
41 unique Pathogenic / Likely Pathogenic· 92 VUS of 196 total submissions
📖
GeneReview available — ENTREP1
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.11LOEUF
pLI 0.000
Z-score 1.15
OE 0.74 (0.511.11)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.62Z-score
OE missense 0.89 (0.800.99)
237 obs / 265.4 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.74 (0.511.11)
00.351.4
Missense OE0.89 (0.800.99)
00.61.4
Synonymous OE0.82
01.21.6
LoF obs/exp: 17 / 22.9Missense obs/exp: 237 / 265.4Syn Z: 1.45
DN
0.6842th %ile
GOF
0.6930th %ile
LOF
0.3746th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

196 submitted variants in ClinVar

Classification Summary

Pathogenic33
Likely Pathogenic8
VUS92
Likely Benign24
Benign25
Conflicting4
33
Pathogenic
8
Likely Pathogenic
92
VUS
24
Likely Benign
25
Benign
4
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
33
0
33
Likely Pathogenic
0
0
8
0
8
VUS
0
79
13
0
92
Likely Benign
1
4
13
6
24
Benign
0
2
22
1
25
Conflicting
4
Total185897186

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

ENTREP1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 3 full-text resultsSearch PubTator3 ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC